Insider Transactions in Q3 2021 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 20
2021
|
Ann Brady PRESIDENT, TBIL |
SELL
Payment of exercise price or tax liability
|
Direct |
3,169
-2.53%
|
$44,366
$14.05 P/Share
|
|
Aug 20
2021
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
6,819
-3.79%
|
$95,466
$14.05 P/Share
|
|
Aug 20
2021
|
Andrew A. Hindman SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
17,464
-9.45%
|
$244,496
$14.05 P/Share
|
|
Aug 20
2021
|
Frank Pasqualone SVP, CHIEF BUSINESS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,779
-0.86%
|
$52,906
$14.05 P/Share
|
|
Aug 20
2021
|
Kenneth R Pitzer SVP, PROD STRAT & COMM PLNG |
SELL
Payment of exercise price or tax liability
|
Direct |
4,307
-1.18%
|
$60,298
$14.05 P/Share
|
|
Aug 20
2021
|
Vijay Sabesan SVP, TECHNICAL OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
5,193
-2.11%
|
$72,702
$14.05 P/Share
|
|
Aug 20
2021
|
Bradford J Shafer EVP, Gen. Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,307
-1.53%
|
$60,298
$14.05 P/Share
|
|
Aug 20
2021
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
11,404
-0.86%
|
$159,656
$14.05 P/Share
|
|
Aug 20
2021
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
SELL
Payment of exercise price or tax liability
|
Direct |
4,307
-1.27%
|
$60,298
$14.05 P/Share
|